N-[[5-methyl-6-(3-methylphenyl)-3-pyridinyl]methyl]-6-(5-methyl-3-pyridinyl)-2,7-naphthyridin-1-amine;6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[[4-(3-methylphenyl)phenyl]methyl]-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1-methylpyrazol-3-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1,3-oxazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(2H-tetrazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1,3-thiazol-5-yl)-2,7-naphthyridin-1-amine

C152H128N30O2S — CID 161231458

About N-[[5-methyl-6-(3-methylphenyl)-3-pyridinyl]methyl]-6-(5-methyl-3-pyridinyl)-2,7-naphthyridin-1-amine;6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[[4-(3-methylphenyl)phenyl]methyl]-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1-methylpyrazol-3-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1,3-oxazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(2H-tetrazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1,3-thiazol-5-yl)-2,7-naphthyridin-1-amine

N-[[5-methyl-6-(3-methylphenyl)-3-pyridinyl]methyl]-6-(5-methyl-3-pyridinyl)-2,7-naphthyridin-1-amine;6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[[4-(3-methylphenyl)phenyl]methyl]-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1-methylpyrazol-3-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1,3-oxazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(2H-tetrazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1,3-thiazol-5-yl)-2,7-naphthyridin-1-amine (PubChem CID 161231458) has the molecular formula C152H128N30O2S and a molecular weight of 2438.97 g/mol. Its IUPAC name is N-[[5-methyl-6-(3-methylphenyl)-3-pyridinyl]methyl]-6-(5-methyl-3-pyridinyl)-2,7-naphthyridin-1-amine;6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[[4-(3-methylphenyl)phenyl]methyl]-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1-methylpyrazol-3-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1,3-oxazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(2H-tetrazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1,3-thiazol-5-yl)-2,7-naphthyridin-1-amine.

Molecular Properties

• Compound Name: N-[[5-methyl-6-(3-methylphenyl)-3-pyridinyl]methyl]-6-(5-methyl-3-pyridinyl)-2,7-naphthyridin-1-amine;6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[[4-(3-methylphenyl)phenyl]methyl]-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1-methylpyrazol-3-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1,3-oxazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(2H-tetrazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1,3-thiazol-5-yl)-2,7-naphthyridin-1-amine
• PubChem CID: 161231458
• Molecular Formula: C152H128N30O2S
• Molecular Weight: 2438.97 g/mol
• Exact Mass: 2437.06
• IUPAC Name: N-[[5-methyl-6-(3-methylphenyl)-3-pyridinyl]methyl]-6-(5-methyl-3-pyridinyl)-2,7-naphthyridin-1-amine;6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[[4-(3-methylphenyl)phenyl]methyl]-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1-methylpyrazol-3-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1,3-oxazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(2H-tetrazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1,3-thiazol-5-yl)-2,7-naphthyridin-1-amine
• SMILES: Cc1cccc(-c2ccc(CNc3nccc4cc(-c5ccn(C)n5)ncc34)cc2)c1.Cc1cccc(-c2ccc(CNc3nccc4cc(-c5cnco5)ncc34)cc2)c1.Cc1cccc(-c2ccc(CNc3nccc4cc(-c5cncs5)ncc34)cc2)c1.Cc1cccc(-c2ccc(CNc3nccc4cc(-c5nn[nH]n5)ncc34)cc2)c1.Cc1cccc(-c2ccc(CNc3nccc4cc(-c5nnc(C)o5)ncc34)cc2)c1.Cc1cncc(-c2cc3ccnc(NCc4cnc(-c5cccc(C)c5)c(C)c4)c3cn2)c1
• InChI: InChI=1S/C28H25N5.C26H23N5.C25H21N5O.C25H20N4O.C25H20N4S.C23H19N7/c1-18-5-4-6-23(9-18)27-20(3)11-21(14-32-27)15-33-28-25-17-31-26(12-22(25)7-8-30-28)24-10-19(2)13-29-16-24;1-18-4-3-5-21(14-18)20-8-6-19(7-9-20)16-29-26-23-17-28-25(15-22(23)10-12-27-26)24-11-13-31(2)30-24;1-16-4-3-5-20(12-16)19-8-6-18(7-9-19)14-28-24-22-15-27-23(13-21(22)10-11-26-24)25-30-29-17(2)31-25;2*1-17-3-2-4-20(11-17)19-7-5-18(6-8-19)13-29-25-22-14-28-23(24-15-26-16-30-24)12-21(22)9-10-27-25;1-15-3-2-4-18(11-15)17-7-5-16(6-8-17)13-26-22-20-14-25-21(23-27-29-30-28-23)12-19(20)9-10-24-22/h4-14,16-17H,15H2,1-3H3,(H,30,33);3-15,17H,16H2,1-2H3,(H,27,29);3-13,15H,14H2,1-2H3,(H,26,28);2*2-12,14-16H,13H2,1H3,(H,27,29);2-12,14H,13H2,1H3,(H,24,26)(H,27,28,29,30)
• InChIKey: UYUNJZOSZZHTOQ-UHFFFAOYSA-N
• XLogP: 34.10
• TPSA: 402.76 Ų
• H-Bond Donors: 7
• H-Bond Acceptors: 32
• Rotatable Bonds: 30
• Heavy Atoms: 185
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2438.97
LogP ≤ 5	34.10
H-Bond Donors ≤ 5	7
H-Bond Acceptors ≤ 10	32

Frequently Asked Questions

What is the IUPAC name of N-[[5-methyl-6-(3-methylphenyl)-3-pyridinyl]methyl]-6-(5-methyl-3-pyridinyl)-2,7-naphthyridin-1-amine;6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[[4-(3-methylphenyl)phenyl]methyl]-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1-methylpyrazol-3-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1,3-oxazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(2H-tetrazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1,3-thiazol-5-yl)-2,7-naphthyridin-1-amine?

The IUPAC name of N-[[5-methyl-6-(3-methylphenyl)-3-pyridinyl]methyl]-6-(5-methyl-3-pyridinyl)-2,7-naphthyridin-1-amine;6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[[4-(3-methylphenyl)phenyl]methyl]-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1-methylpyrazol-3-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1,3-oxazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(2H-tetrazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1,3-thiazol-5-yl)-2,7-naphthyridin-1-amine (CID 161231458) is N-[[5-methyl-6-(3-methylphenyl)-3-pyridinyl]methyl]-6-(5-methyl-3-pyridinyl)-2,7-naphthyridin-1-amine;6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[[4-(3-methylphenyl)phenyl]methyl]-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1-methylpyrazol-3-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1,3-oxazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(2H-tetrazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1,3-thiazol-5-yl)-2,7-naphthyridin-1-amine.

What is the SMILES notation for N-[[5-methyl-6-(3-methylphenyl)-3-pyridinyl]methyl]-6-(5-methyl-3-pyridinyl)-2,7-naphthyridin-1-amine;6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[[4-(3-methylphenyl)phenyl]methyl]-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1-methylpyrazol-3-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1,3-oxazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(2H-tetrazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1,3-thiazol-5-yl)-2,7-naphthyridin-1-amine?

The canonical SMILES for N-[[5-methyl-6-(3-methylphenyl)-3-pyridinyl]methyl]-6-(5-methyl-3-pyridinyl)-2,7-naphthyridin-1-amine;6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[[4-(3-methylphenyl)phenyl]methyl]-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1-methylpyrazol-3-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1,3-oxazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(2H-tetrazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1,3-thiazol-5-yl)-2,7-naphthyridin-1-amine is Cc1cccc(-c2ccc(CNc3nccc4cc(-c5ccn(C)n5)ncc34)cc2)c1.Cc1cccc(-c2ccc(CNc3nccc4cc(-c5cnco5)ncc34)cc2)c1.Cc1cccc(-c2ccc(CNc3nccc4cc(-c5cncs5)ncc34)cc2)c1.Cc1cccc(-c2ccc(CNc3nccc4cc(-c5nn[nH]n5)ncc34)cc2)c1.Cc1cccc(-c2ccc(CNc3nccc4cc(-c5nnc(C)o5)ncc34)cc2)c1.Cc1cncc(-c2cc3ccnc(NCc4cnc(-c5cccc(C)c5)c(C)c4)c3cn2)c1.

What is the InChIKey of N-[[5-methyl-6-(3-methylphenyl)-3-pyridinyl]methyl]-6-(5-methyl-3-pyridinyl)-2,7-naphthyridin-1-amine;6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[[4-(3-methylphenyl)phenyl]methyl]-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1-methylpyrazol-3-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1,3-oxazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(2H-tetrazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1,3-thiazol-5-yl)-2,7-naphthyridin-1-amine?

The InChIKey is UYUNJZOSZZHTOQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H25N5.C26H23N5.C25H21N5O.C25H20N4O.C25H20N4S.C23H19N7/c1-18-5-4-6-23(9-18)27-20(3)11-21(14-32-27)15-33-28-25-17-31-26(12-22(25)7-8-30-28)24-10-19(2)13-29-16-24;1-18-4-3-5-21(14-18)20-8-6-19(7-9-20)16-29-26-23-17-28-25(15-22(23)10-12-27-26)24-11-13-31(2)30-24;1-16-4-3-5-20(12-16)19-8-6-18(7-9-19)14-28-24-22-15-27-23(13-21(22)10-11-26-24)25-30-29-17(2)31-25;2*1-17-3-2-4-20(11-17)19-7-5-18(6-8-19)13-29-25-22-14-28-23(24-15-26-16-30-24)12-21(22)9-10-27-25;1-15-3-2-4-18(11-15)17-7-5-16(6-8-17)13-26-22-20-14-25-21(23-27-29-30-28-23)12-19(20)9-10-24-22/h4-14,16-17H,15H2,1-3H3,(H,30,33);3-15,17H,16H2,1-2H3,(H,27,29);3-13,15H,14H2,1-2H3,(H,26,28);2*2-12,14-16H,13H2,1H3,(H,27,29);2-12,14H,13H2,1H3,(H,24,26)(H,27,28,29,30).

What are the key properties of N-[[5-methyl-6-(3-methylphenyl)-3-pyridinyl]methyl]-6-(5-methyl-3-pyridinyl)-2,7-naphthyridin-1-amine;6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[[4-(3-methylphenyl)phenyl]methyl]-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1-methylpyrazol-3-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1,3-oxazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(2H-tetrazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1,3-thiazol-5-yl)-2,7-naphthyridin-1-amine?

N-[[5-methyl-6-(3-methylphenyl)-3-pyridinyl]methyl]-6-(5-methyl-3-pyridinyl)-2,7-naphthyridin-1-amine;6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[[4-(3-methylphenyl)phenyl]methyl]-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1-methylpyrazol-3-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1,3-oxazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(2H-tetrazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1,3-thiazol-5-yl)-2,7-naphthyridin-1-amine has a molecular weight of 2438.97 g/mol, XLogP of 34.10, 30 rotatable bonds, 7 hydrogen bond donors, and 32 hydrogen bond acceptors.

Where does this data come from?

All data for N-[[5-methyl-6-(3-methylphenyl)-3-pyridinyl]methyl]-6-(5-methyl-3-pyridinyl)-2,7-naphthyridin-1-amine;6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[[4-(3-methylphenyl)phenyl]methyl]-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1-methylpyrazol-3-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1,3-oxazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(2H-tetrazol-5-yl)-2,7-naphthyridin-1-amine;N-[[4-(3-methylphenyl)phenyl]methyl]-6-(1,3-thiazol-5-yl)-2,7-naphthyridin-1-amine is sourced from PubChem (CID 161231458), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).